Literature DB >> 10806367

Molecular dissection of the Schwann cell specific promoter of the PMP22 gene.

D Sabéran-Djoneidi1, V Sanguedolce, Z Assouline, N Lévy, E Passage, M Fontés.   

Abstract

PMP22, one of the major components of myelin, is overexpressed in Charcot-Marie-Tooth type 1A (CMT1A) patients. In an attempt to determine the mechanisms by which the expression of this gene is regulated (with a view to lowering its expression in CMT1A patients), we subcloned genomic fragments covering 6kb of the promoter region in an expression vector containing the beta-galactosidase gene as reporter, and used these in transfection assays. We show that the 300bp upstream of the transcription start contain the elements required for Schwann cell specific expression of the reporter gene. This minimal promoter activity appears to be under the control of a silencer element sensitive to cAMP, located between -0.3kb and -3. 5kb from the start of transcription. Computer analysis of 2kb of the promoter predicted the presence of transcription factor binding sites, including CREB (which may be involved in the response of PMP22 expression to cAMP stimulation) and steroid receptors. Using constructs with or without the CREB sites, we were able to demonstrate that these sites are involved in silencing the PMP22 promoter activity. Lastly, we identified a region containing blocks of polymorphic CA repeats, located close to the CREB binding site, which may further influence the transcriptional activity of PMP22.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806367     DOI: 10.1016/s0378-1119(00)00116-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  18 in total

Review 1.  Genetic approaches to the treatment of inherited neuromuscular diseases.

Authors:  Bhavya Ravi; Anthony Antonellis; Charlotte J Sumner; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 2.  Inherited neuropathies.

Authors:  Jun Li
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

3.  Developing myelin specific promoters for schwannoma gene therapy.

Authors:  Sherif G Ahmed; Farnaz Hadaegh; Gary J Brenner
Journal:  J Neurosci Methods       Date:  2019-05-22       Impact factor: 2.390

4.  Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22.

Authors:  Erin A Jones; Megan H Brewer; Rajini Srinivasan; Courtney Krueger; Guannan Sun; Kira N Charney; Sunduz Keles; Anthony Antonellis; John Svaren
Journal:  Hum Mol Genet       Date:  2011-12-15       Impact factor: 6.150

5.  Regulation of the PMP22 gene through an intronic enhancer.

Authors:  Erin A Jones; Camila Lopez-Anido; Rajini Srinivasan; Courtney Krueger; Li-Wei Chang; Rakesh Nagarajan; John Svaren
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

6.  Progesterone synthesized by Schwann cells during myelin formation regulates neuronal gene expression.

Authors:  J R Chan; P M Rodriguez-Waitkus; B K Ng; P Liang; M Glaser
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

7.  The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes.

Authors:  K Inoue; K Dewar; N Katsanis; L T Reiter; E S Lander; K L Devon; D W Wyman; J R Lupski; B Birren
Journal:  Genome Res       Date:  2001-06       Impact factor: 9.043

Review 8.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

9.  Ascorbic Acid and gene expression: another example of regulation of gene expression by small molecules?

Authors:  Sophie Belin; Ferdinand Kaya; Stéphane Burtey; Michel Fontes
Journal:  Curr Genomics       Date:  2010-03       Impact factor: 2.236

10.  Functional and comparative genomics analyses of pmp22 in medaka fish.

Authors:  Junji Itou; Mikita Suyama; Yukio Imamura; Tomonori Deguchi; Kazuhiro Fujimori; Shunsuke Yuba; Yutaka Kawarabayasi; Takashi Kawasaki
Journal:  BMC Neurosci       Date:  2009-06-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.